CLEAN : First large-scale malaria vaccine trials for Africa

The video discusses health initiatives in Ethiopia and Western Kenya, highlighting partnerships and trials. It emphasizes World Malaria Day, noting the ongoing threat of malaria, especially to children in Sub-Saharan Africa. The development of malaria vaccines, particularly RTS S, is promising, with pilot programs set in Ghana, Kenya, and Malawi. The program involves collaboration with local health ministries and GSK, which provides the vaccine free for the pilot, aiming to integrate it with existing health measures.

What role does GSK pharmaceutical company play in the malaria vaccine program?

How does the malaria vaccine complement existing health measures in Africa?